S C R U B B I N G U P
The robotic catheterisation systems market is experiencing a development in terms of digitalisation of instruments with it being a main factor in the advancement of automated and integrated cardiovascular interventional labs . The developments in robotic technology are occurring at a rapid pace , which would assist hospitals in cutting down on catheterisation lab costs , chiefly in inaccessible and isolated areas . Using the findings from Future Market Insight ’ s report , ‘ Robotic Catheterisation Systems Market ’, Sabyasachi Ghosh , Associate Vice President at Future Market Insights , dives into the study .
FMI ’ ANALYST ’ S VIEW ON THE ROBOTIC CATHETERISATION SYSTEMS MARKET
The global sales of robotic catheterisation systems are estimated to be worth US $ 54.4 million in 2025 and anticipated to reach a value of US $ 190.2 million by 2035 . Sales are projected to rise at a CAGR of 13.3 % over the forecast period between 2025 and 2035 . The revenue generated by robotic catheterisation systems in 2023 was US $ 42.0 million .
Key industry highlights
Long-term cost efficiency of robotic catheterisation systems demanded in the markets
While the initial costs of robotic catheter systems may be steep , economically , they are much more efficient in the long-run . These high-tech systems are associated with faster and more accurate procedures that lead to a direct decrease in procedure times and enhance patient outcomes .
This , in turn , leads to shorter less costly hospital stays . Robotic systems also minimise the risk of complications and human error , which may result in cost related to treatment and recovery for the patient . These systems , through greater accuracy in catheter placement and reduced rates of adverse events , significantly reduce the need for secondary surgical interventions , thus minimising hospitalisations and other medical interventions .
Further , accuracy improves such clinical outcomes as readmissions and rehospitalisations , which decreases overall increment in costs of healthcare . Over time , the financial advantages of operational efficiencies and better patient outcomes arising from robotic systems make it a capitalefficient investment toward the healthcare institutions . This is prompting hospitals into realising the long-term financial benefits of robotic catheterisation technology .
Enhanced precision and safety with robotic catheterisation systems driving the demand
Such robotic-assisted procedures , whereby precision , dexterity and control over catheterisation are maximised , produce satisfactory patient results-and a better chance of success for doctors involved .
www . intelligenthealth . tech 67